|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/21 | (2006.01) |
| A61K 38/21 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 31/14 | (2006.01) | ||
| A61P 31/14 | (2018.01) |
| (11) | Number of the document | 3957319 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21164362.2 |
| Date of filing the European patent application | 2017-02-17 | |
| (97) | Date of publication of the European application | 2022-02-23 |
| (45) | Date of publication and mention of the grant of the patent | 2024-12-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201662297759 P | 2016-02-19 | US |
| (72) |
MARTINS, Eduardo Bruno , US
|
| (73) |
EIT Pharma, Inc. ,
11620 Wilshire Boulevard
Suite 350, Los Angeles, CA 90025,
US
|
| (54) | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA |
| TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA |